Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study.
E HodakShany ShermanE PapadavidM BagotC QuerfeldPietro QuaglinoH M PrinceP L Ortiz-RomeroR StadlerR KnoblerEmmanuella GuenovaT EstrachA PatsatsiYael A LeshemH Prague-NavehE BertiS Alberti-ViolettiR CowanC JonakVasiliki A NikolaouC MitteldorfOleg E AkilovLarisa J GeskinR MatinMarie Beylot-BarryL VakevaJ A SanchesO ServitjeS WeatherheadM WobserJ YooM BayneA BatesG DunnillM MarschalkoA M BuschotsUlrike WehkampF EvisonE HongIris Amitay-LaishR StranzenbachM VermeerR WillemzeW KempfL CerroniSean WhittakerY H KimJulia J Scarisbricknull nullPublished in: The British journal of dermatology (2020)
Physical examination was a poor determinant of LN enlargement or involvement. Presence of plaques was associated with a significant increase in identification of enlarged or involved LNs in patients with early-stage presentation of MF, which may be important when deciding who to image. Imaging increases the detection rate of stage IIA MF, and identifies rare cases of extensive lymphomatous nodes, upstaging them to advanced-stage IVA2.